FY26 Revenue Hits $8.1M as Wholesale Surges 178% at The Calmer Co.

Record Revenue Growth Amid Strategic Transition

The Calmer Co. International Limited (ASX:CCO) has reported a milestone $8.1 million in revenue for the fiscal year ended June 30, 2026, marking a modest 1% increase over the previous year. This growth was underpinned by a remarkable 178% surge in wholesale sales and a solid 30% lift in retail revenue, reflecting the company's ongoing evolution from a niche kava producer into a global botanical ingredients and wellness business.

Australian retail expansion was a highlight, with the Fiji Kava® brand securing a #1 position in Coles’ stress category and successfully implementing pricing with major supermarket chains including Coles and Woolworths. The company’s presence in the US market also strengthened, particularly through Amazon and wholesale channels, where wholesale revenue soared by 927% to $1.5 million, reinforcing The Calmer Co.’s strategic focus on the world’s largest natural wellness market.

Financial Performance and Funding Pressures

Despite the revenue gains, The Calmer Co. recorded a statutory net loss of $3.8 million for FY26, a slight improvement from a $4.0 million loss in FY25. The loss reflects ongoing investments in manufacturing capability, marketing, and product development, alongside disciplined cost management efforts including reductions in employment and marketing expenses.

The balance sheet reveals accumulated losses of $37.2 million and net current liabilities of $1.15 million, with cash reserves standing at $668,732 at year-end. The company raised $1.5 million through a share placement during the year and has since launched a $3.5 million renounceable entitlement offer to bolster working capital and support growth initiatives. This offer, which closed in mid-August 2026, is partly underwritten and includes participation from directors, providing some cushion amid funding uncertainties.

Operational Advances and Strategic Pillars

The company has continued to invest in its vertically integrated supply chain and manufacturing excellence, advancing premium CO2 extraction technology that broadens its addressable market for high-value kava ingredients. These capabilities support both branded consumer products and B2B botanical ingredient sales, positioning The Calmer Co. to capture expanding demand in functional wellness categories.

Direct-to-consumer channels faced challenges, with owned digital sales underperforming following a platform migration and operational reset. However, Amazon remains a strong e-commerce performer, particularly in the US, driving 18% growth in total e-commerce revenue to $3.2 million.

The Calmer Co.’s four strategic pillars, regional supply chain innovation, direct-to-consumer growth, profitable retail expansion, and wholesale ingredient commercialisation, continue to guide its efforts to scale sustainably while maintaining cost discipline.

Governance and Going Concern Considerations

The Board acknowledges a material uncertainty regarding the company’s ability to continue as a going concern, contingent on the successful completion of funding initiatives and achievement of forecast sales and cash flow targets. Management has prepared cash flow forecasts incorporating anticipated growth and cost controls, but the outcome remains dependent on shareholder participation in the entitlement offer and other funding sources.

Governance disclosures confirm adherence to ASX Corporate Governance Principles, with the full Board overseeing audit, risk, nomination, and remuneration responsibilities given the company's current scale.

What to Watch Next

The Calmer Co.’s progress in commercialising premium kava ingredients and expanding retail distribution sets a foundation for potential growth. However, the company’s near-term trajectory hinges on the capital raise outcomes and its ability to convert emerging market opportunities into profitable operations. Investors will be watching closely for quarterly updates on sales momentum, margin improvements, and operational efficiencies as FY27 unfolds.